UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$288M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$215M |
| 3 |
Tractor Supply
TSCO
|
+$157M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
PayPal
PYPL
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$339M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$244M |
| 3 |
PX
Praxair Inc
PX
|
+$218M |
| 4 |
Meta Platforms (Facebook)
META
|
+$182M |
| 5 |
Adobe
ADBE
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 14.9% |
| 3 | Financials | 14.08% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
MacroGenics
MGNX
$255M
| $6.61M | 0.01% |
520,203
+41,087
| +9% | +$689K |
|
952
PBF Energy
PBF
$7.26B
| $6.6M | 0.01% |
202,119
+42,179
| +26% | +$1.7M |
|
953
Toro Company
TTC
$9.35B
| $6.59M | 0.01% |
118,010
+11,046
| +10% | +$642K |
|
|
KW
954
DELISTED
Kennedy-Wilson Holdings
KW
| $6.59M | 0.01% |
362,598
+7,872
| +2% | +$151K |
|
955
Fate Therapeutics
FATE
$290M
| $6.59M | 0.01% |
513,504
+447,726
| +681% | +$6.24M |
|
956
MDU Resources
MDU
$4.34B
| $6.58M | 0.01% |
726,351
+41,511
| +6% | +$405K |
|
957
Wyndham Hotels & Resorts
WH
$5.58B
| $6.58M | 0.01% |
145,082
+4,222
| +3% | +$205K |
|
|
ONCE
958
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $6.58M | 0.01% |
168,005
-4,435
| -3% | -$192K |
|
959
Pool Corp
POOL
$7.31B
| $6.54M | 0.01% |
43,967
-2
| -0% | -$299 |
|
960
iShares Russell 2000 Growth ETF
IWO
$14.8B
| $6.53M | 0.01% |
38,873
+4,866
| +14% | +$908K |
|
961
Xencor
XNCR
$1.49B
| $6.49M | 0.01% |
179,490
+146,385
| +442% | +$5.37M |
|
|
WPX
962
DELISTED
WPX Energy, Inc.
WPX
| $6.47M | 0.01% |
570,127
-80,427
| -12% | -$1.22M |
|
|
FLG
963
Flagstar Bank National Association
FLG
$5.9B
| $6.45M | 0.01% |
228,546
-375,057
| -62% | -$10.9M |
|
964
iShares MSCI Emerging Markets ETF
EEM
$29.2B
| $6.44M | 0.01% |
164,910
+4,952
| +3% | +$198K |
|
965
Prosperity Bancshares
PB
$8.88B
| $6.44M | 0.01% |
103,390
+37,656
| +57% | +$2.48M |
|
966
Americold
COLD
$4.11B
| $6.43M | 0.01% |
251,739
+21,778
| +9% | +$559K |
|
967
Empire State Realty Trust
ESRT
$843M
| $6.43M | 0.01% |
451,548
+8,851
| +2% | +$138K |
|
968
EQT Corp
EQT
$32.3B
| $6.42M | 0.01% |
339,664
-1,150,325
| -77% | -$23.3M |
|
969
Reliance Steel & Aluminium
RS
$21.3B
| $6.41M | 0.01% |
90,078
-7,274
| -7% | -$574K |
|
|
IDTI
970
DELISTED
Integrated Device Technology I
IDTI
| $6.4M | 0.01% |
132,149
-208,578
| -61% | -$9.85M |
|
971
AptarGroup
ATR
$8.63B
| $6.4M | 0.01% |
67,986
+2,376
| +4% | +$242K |
|
972
AMN Healthcare
AMN
$1.19B
| $6.37M | 0.01% |
112,481
+34,276
| +44% | +$1.92M |
|
973
Infosys
INFY
$50.1B
| $6.35M | 0.01% |
666,900
+37,890
| +6% | +$362K |
|
974
Grupo Cibest SA
CIB
$21.4B
| $6.35M | 0.01% |
166,621
+13,100
| +9% | +$523K |
|
|
WMGI
975
DELISTED
Wright Medical Group Inc
WMGI
| $6.34M | 0.01% |
232,739
-452,875
| -66% | -$12.5M |
|
Similar funds
UBS AM's Q4 2018 Portfolio in Review
As of Q4 2018, UBS AM held 2,899 positions worth $116B, down 14% from $135B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS AM's Q4 2018 filing shows 140 new, 1,359 increased, 845 reduced and 130 closed positions. Its largest new stake was Linde: 1,823,057 shares worth $284M. The largest sale was Aetna Inc, an estimated $339M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2018 buy was Linde: 1,823,057 shares worth $284M.
- UBS AM added most to iShares US Treasury Bond ETF in Q4 2018, an estimated $215M increase.
- UBS AM's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $182M.
- UBS AM fully exited Aetna Inc in Q4 2018, selling an estimated $339M.
- UBS AM's ten largest holdings make up 17% of its $116B portfolio in Q4 2018.
- UBS AM opened 140 new positions and closed 130 in Q4 2018.
- UBS AM's portfolio value fell 14% quarter-over-quarter to $116B.
Based on UBS AM's 13F filing for Q4 2018, filed 13 Feb 2019.